Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus general anesthesia for dental treatment in adults with intellectual disability and dentophobia
NL-OMON43058Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexmedetomidine in intellectual disability (ID) and Dentophobia (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Completion of dental treatment under dexmedetomidine sedation, Completion of dental treatment under general anesthesia and 2 more. Started Nov 2016; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
intellectual disability (ID)Dentophobia
Beyond the preview
Go deeper on NL-OMON43058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43058.